• Home
  • Categories
Contact
Menu
CONTACT
Search
Observational Study

Others

  • May 2, 2025
  • Posted by author-avatar myadmin
12 Nov
Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Unive...

Continue reading

Observational Study

Lung Cancer

  • December 9, 2024
  • Posted by author-avatar myadmin
23 Sep
Plasma Molecular Profiling in ALK inhibitor resistant non-small cell lung cancer (ARTOG-004) Non Small Cell Lung Cancer with ALK Inh...

Continue reading

Observational Study

Rare Cancers

  • November 12, 2023
  • Posted by author-avatar myadmin
23 Sep
Promoting genomic medicine throughout Asia (MASTER KEY ASIA) University of Malaya Medical Centre (UMMC) PRINCIPAL INVESTIGATOR D...

Continue reading

Observational Study

Nasopharyngeal Carcinoma

  • February 27, 2025
  • Posted by author-avatar myadmin
23 Sep
Asian multicenter prospective study of circulating tumor DNA sequencing (A-TRAIN Nasopharyngeal Carcinoma Project) Nasopharyngeal Ca...

Continue reading

Observational Study

Cervical Cancer Ovarian Clear Cell Carcinoma N

  • November 13, 2024
  • Posted by author-avatar myadmin
23 Sep
A Phase 3 Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Vers...

Continue reading

Observational Study

Prostate Cancer

  • November 12, 2023
  • Posted by author-avatar myadmin
23 Sep
Biomarker Study to Determine Frequency of DNA-repair Defects in Men with Metastatic Prostate Cancer (Observational) (PREVALENCE) Met...

Continue reading

Observational Study

Observational Study

  • December 28, 2023
  • Posted by author-avatar myadmin
22 Sep

Continue reading

Observational Study

Breast Cancer

  • November 12, 2023
  • Posted by author-avatar myadmin
22 Sep
Studies of Epigenetic Changes in Blood Samples in Breast Cancer Patients (EPIGENECTIC) Breast Cancer Kuala Lumpur Hospital (HKL) ...

Continue reading

Copyright © 2023 Malaysian Oncological Society. All Rights Reserved.
  • Home
  • Categories